JP2023543056A5 - - Google Patents

Info

Publication number
JP2023543056A5
JP2023543056A5 JP2023519466A JP2023519466A JP2023543056A5 JP 2023543056 A5 JP2023543056 A5 JP 2023543056A5 JP 2023519466 A JP2023519466 A JP 2023519466A JP 2023519466 A JP2023519466 A JP 2023519466A JP 2023543056 A5 JP2023543056 A5 JP 2023543056A5
Authority
JP
Japan
Prior art keywords
gene
site
specific
item
interferant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519466A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543056A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/052720 external-priority patent/WO2022072546A2/en
Publication of JP2023543056A publication Critical patent/JP2023543056A/ja
Publication of JP2023543056A5 publication Critical patent/JP2023543056A5/ja
Pending legal-status Critical Current

Links

JP2023519466A 2020-09-29 2021-09-29 複数遺伝子の発現を阻害するための組成物及び方法 Pending JP2023543056A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063085013P 2020-09-29 2020-09-29
US63/085,013 2020-09-29
US202163216487P 2021-06-29 2021-06-29
US63/216,487 2021-06-29
PCT/US2021/052720 WO2022072546A2 (en) 2020-09-29 2021-09-29 Compositions and methods for inhibiting the expression of multiple genes

Publications (2)

Publication Number Publication Date
JP2023543056A JP2023543056A (ja) 2023-10-12
JP2023543056A5 true JP2023543056A5 (https=) 2024-10-07

Family

ID=80951794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519466A Pending JP2023543056A (ja) 2020-09-29 2021-09-29 複数遺伝子の発現を阻害するための組成物及び方法

Country Status (7)

Country Link
US (1) US20230374549A1 (https=)
EP (1) EP4222259A4 (https=)
JP (1) JP2023543056A (https=)
KR (1) KR20230079181A (https=)
AU (1) AU2021354159A1 (https=)
CA (1) CA3193868A1 (https=)
WO (1) WO2022072546A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190255106A1 (en) 2016-09-07 2019-08-22 Flagship Pioneering Inc. Methods and compositions for modulating gene expression
WO2025226912A1 (en) * 2024-04-26 2025-10-30 Sri International Cell-type specific delivery of gene editors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190255106A1 (en) * 2016-09-07 2019-08-22 Flagship Pioneering Inc. Methods and compositions for modulating gene expression
US20220380760A1 (en) * 2018-10-15 2022-12-01 Flagship Pioneering Innovations V, Inc. Disrupting genomic complex assembly in fusion genes

Similar Documents

Publication Publication Date Title
JP2023543218A5 (https=)
Wu et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
JP6799058B2 (ja) アレル選択的な遺伝子編集およびその使用
JP2024501383A (ja) エピジェネティック編集のための組成物および方法
Zhang et al. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon‐γ
JP2023543056A5 (https=)
CN109196118A (zh) 用于抑制nlrp3基因表达的组合物及其用途
JP2019531763A5 (https=)
JPH025760B2 (https=)
JP4787409B2 (ja) 治療用ホスホジエステラーゼ阻害剤
US12584131B2 (en) Methods of gene therapy
JP2023517326A5 (https=)
AU2020352984A1 (en) Methods and compositions for modulating frataxin expression and treating Friedrich's ataxia
Sowinska et al. The homeostatic function of Regnase‐2 restricts neuroinflammation
JP2023543056A (ja) 複数遺伝子の発現を阻害するための組成物及び方法
CN111182925A (zh) 阳离子核酸清除剂及其用途
CN118043461A (zh) 方法
CN118460655B (zh) 抑制FXI基因表达的siRNA的制备方法
JP2025511184A5 (https=)
US20220267756A1 (en) Compositions and methods for modulating genomic complex integrity index
WO2017043639A1 (ja) キメラデコイ
Li et al. Immunity of turbot Induced by inactivated vaccine of Aeromonas salmonicida from the perspective of DNA methylation
CN1829795A (zh) 预防和治疗细菌以及真菌病理学的核苷酸
JP2004329216A (ja) p55腫瘍壊死因子受容体(TNF−R)に対するプロモーター配列ならびにその製造および使用
He et al. Mitochondrial Dysfunction-Triggered Innate Immune Response and Its Therapeutic Implications